Mindera Health™ Announces Issuance of Additional International Patent Coverage for Dermal Biomarker Patch Platform
About Mind.Px by Mindera Health Mind.Px is the flagship test of Mindera Health, designed to prospectively predict a patient’s response to expensive biologic drug classes prior to therapeutic selection and treatment. Using a scalable, minimally invasive dermal biomarker patch that captures over 7,000 biomarkers per sample along with data analytics, Mind.Px materially improves patient outcomes and significantly reduces healthcare system costs of expensive biologic treatments. San Diego, CA, Oct. 1
Source: yahoo.com